about
Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients.Gene variations of nitric oxide synthase regulate the effects of a saturated fat rich meal on endothelial function.Postprandial antioxidant effect of the Mediterranean diet supplemented with coenzyme Q10 in elderly men and womenMediterranean and low-fat diets improve endothelial function in hypercholesterolemic men.NOS3 Glu298Asp polymorphism interacts with virgin olive oil phenols to determine the postprandial endothelial function in patients with the metabolic syndrome.Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemiaDietary fat modifies lipid metabolism in the adipose tissue of metabolic syndrome patients.R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study.Interleukin 1B variant -1473G/C (rs1143623) influences triglyceride and interleukin 6 metabolism.Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects.Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study).Dietary fat, genes and insulin sensitivity.Olive oil and the haemostatic system.Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study.CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics: A clinical trial comparing the efficacy of a Mediterranean diet rich in olive oil versus a low-faEffects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes.Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).Effects of functional olive oil enriched with its own phenolic compounds on endothelial function in hypertensive patients. A randomised controlled trial.White fish reduces cardiovascular risk factors in patients with metabolic syndrome: the WISH-CARE study, a multicenter randomized clinical trial.Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia.Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.ABCA1 gene variants regulate postprandial lipid metabolism in healthy men.[Clinical significance of increased serum ferritin levels].Validation of a food frequency questionnaire in Spanish patients with familial hypercholesterolaemia.Predictive factors of achieving therapeutic goals of hypertriglyceridemia.[Glucocorticoids and immunoglobulins in an acute respiratory distress syndrome secondary to varicella pneumoniae].A polymorphism exon 1 variant at the locus of the scavenger receptor class B type I (SCARB1) gene is associated with differences in insulin sensitivity in healthy people during the consumption of an olive oil-rich diet.Dietary fat differentially influences regulatory endothelial function during the postprandial state in patients with metabolic syndrome: from the LIPGENE study.The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects.The -514 C/T polymorphism in the hepatic lipase gene promoter is associated with insulin sensitivity in a healthy young population.A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T>C modulates postprandial lipoprotein metabolism.Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR.Autosomal recessive hypercholesterolemia in Spain.Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis.PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.Expression of proinflammatory, proatherogenic genes is reduced by the Mediterranean diet in elderly people.
P50
Q33227139-C14EA96D-3A18-49C9-9863-513B1FD470BDQ33703362-63CD8451-33B8-4BDB-8CFC-145D4F3469C9Q33775791-6D82CF05-9DB5-4883-A510-7DCBF4C9D2FEQ33951954-08AADA43-8573-4E72-959E-75B6D53E8DFDQ33982380-F510A092-7BF3-461F-AF1A-F78D2AC582ABQ34002153-AB62EECD-A133-4265-92B8-846CC461C3ECQ34212919-4393E105-8198-40C1-8172-F9C6FDF0E24AQ34871660-9C20620A-E391-4C40-B28A-93B5CC43E858Q34894496-88833550-2595-405A-BB8E-0C37525D8E1DQ35853626-8FC7A264-1A7A-4329-B708-2EDAF1F6AF80Q35985631-979A7C3B-6B20-4663-BB9F-43845ED073B3Q36685079-F2946808-0687-4416-BB9B-C8DDA5F86EC4Q36945777-EB2EE570-3EA0-4F81-9F66-260113C674FCQ36982064-A44DE927-0B65-4EAD-8208-D7066E69F306Q37012221-ADD062A4-148C-4435-899D-87829B10A00FQ37463331-DF206770-9B34-4F37-AC97-67C47513BC50Q38087382-B759478F-FD1A-4C5E-B2D7-97091715FD41Q38379714-92E017A9-0DF5-4704-889D-6A45EB0E3508Q38389827-C4B44052-C41E-4E88-933E-2113169477A4Q38425019-DDB32BE3-A370-4B82-93F3-C7BE5DCBA800Q38437321-C9727C1A-46EF-43B0-95EA-970F97F690A3Q39246303-ECFC1181-A904-45D4-82ED-B821D2E03D85Q40251610-75080982-A390-4112-BEB6-8CB4F443F2D6Q40619588-B1941C19-EE6B-4090-869D-8948F4566030Q40816130-1F6E4F5A-CD56-4864-BE79-2FB6075FCE8FQ44256254-20CCC281-E36A-4C12-A0DF-2B4BEBA4CA7BQ44520788-C5375782-8C7C-42F1-B599-5B90295F4893Q44720734-130AEAAF-16C7-4108-95EF-0EE418C249D4Q44794203-A35F84F8-0F26-4751-A817-2EC8A5811007Q45238662-646687F0-09E5-45B6-8810-B882964F3908Q45253005-FEB92689-7BFB-4330-A687-C168AA036962Q46233800-E2FDC7CA-8D99-4E27-951C-825D8ABAF63BQ46430487-F2D91D3F-B13E-4949-A750-3051221C5E92Q46874175-473E7C25-D66A-428D-9337-25425786678AQ47228533-04640132-9C92-43C5-BFF8-2D09C73A759CQ47289562-014E2C72-B8B8-476A-85C4-19E45C2D6B06Q51030758-6A9F11D3-22E5-4E9E-9D68-B6F19E606C09Q51052660-410CB19E-3B5A-43F1-9239-D624DF10A0ADQ51279566-B414330D-0C82-4A5C-9EFD-A067E6038839Q51365300-46C02580-1022-4961-A1D3-6B5CFEA7DDE1
P50
description
researcher ORCID ID = 0000-0002-4584-7366
@en
wetenschapper
@nl
name
Francisco Fuentes Jiménez
@ast
Francisco Fuentes Jiménez
@en
Francisco Fuentes Jiménez
@es
Francisco Fuentes Jiménez
@nl
type
label
Francisco Fuentes Jiménez
@ast
Francisco Fuentes Jiménez
@en
Francisco Fuentes Jiménez
@es
Francisco Fuentes Jiménez
@nl
prefLabel
Francisco Fuentes Jiménez
@ast
Francisco Fuentes Jiménez
@en
Francisco Fuentes Jiménez
@es
Francisco Fuentes Jiménez
@nl
P1153
7007016134
P21
P31
P496
0000-0002-4584-7366